Compare Immunovant Inc. Common Stock (IMVT) vs Planet Labs (PL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Planet Labs — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Planet Labs trades at $17.39 (market cap $6.46B). The key difference: Immunovant Inc. Common Stock and Planet Labs are close in size by market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Planet Labs for 4 Days on average.
| IMVT | PL | |
|---|---|---|
Market Cap | $6.62B | $6.46B |
Volume | 1,131,364 | 10,188,839 |
Sector | Health | Industrials |
52-Week High | $44.96 | $51.40 |
52-Week Low | $17.03 | $11.16 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $5.72B | $6.09B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Planet Labs
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →
